Global Cell and Gene Therapy Supply Chain and Logistics Supply, Demand and Key Producers, 2026-2032
The global Cell and Gene Therapy Supply Chain and Logistics market size is expected to reach $ 10816 million by 2032, rising at a market growth of 6.7% CAGR during the forecast period (2026-2032).
Cell and Gene Therapy Supply Chain and Logistics refers to a comprehensive, professional management and transportation system designed to ensure the safety, efficiency, and traceability of CGT drugs throughout the entire process from production to patients. Its core challenges lie in the highly personalized nature, extremely short shelf life, and stringent cryogenic requirements of CGT products. This system encompasses cold chain collection and transportation of biological samples, global sourcing of raw materials required for GMP production, cryogenic distribution of finished drugs, and a real-time temperature monitoring and traceability system throughout the entire process. Each step must strictly adhere to GMP standards to ensure cell viability and sterility; any temperature deviation or delay can lead to product failure. As the lifeline connecting laboratories, factories, and clinical settings, a high-quality supply chain and logistics are crucial for the commercial success of CGT drugs.
The global Cell and Gene Therapy Supply Chain and Logistics market is experiencing rapid growth driven by the accelerated commercialization of CGT drugs and the globalization of clinical trials. North America and Europe, as mature markets, leverage their leading cold chain technologies, comprehensive air networks, and stringent regulations to hold leading positions in cryogenic cold chain logistics, supply chain traceability systems, and global temperature-controlled container services. The Asia-Pacific region is the fastest-growing and most demand-driven sector. China and Southeast Asian countries, driven by a surge in cell therapy clinical research, the expansion of local production facilities, and cross-border medical needs, are rapidly developing cryogenic transportation networks, integrating with hospital supply chains, and establishing real-time monitoring platforms, leading to the rapid rise of local logistics service providers. The industry as a whole is accelerating its evolution towards end-to-end visualization, unmanned intelligent monitoring, and global supply chain integration.
This report studies the global Cell and Gene Therapy Supply Chain and Logistics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy Supply Chain and Logistics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy Supply Chain and Logistics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell and Gene Therapy Supply Chain and Logistics total market, 2021-2032, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Cell and Gene Therapy Supply Chain and Logistics total market, key domestic companies, and share, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics revenue by player, revenue and market share 2021-2026, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics total market by Type, CAGR, 2021-2032, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Cell and Gene Therapy Supply Chain and Logistics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Be The Match BioTherapies, Biocair, Marken, World Courier, MAK-SYSTEM, Cryoport, Brooks Life Sciences, Hypertrust Patient Data Care, Haemonetics, MasterControl, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Cell and Gene Therapy Supply Chain and Logistics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Cell and Gene Therapy Supply Chain and Logistics Market, By Region:
1. How big is the global Cell and Gene Therapy Supply Chain and Logistics market?
2. What is the demand of the global Cell and Gene Therapy Supply Chain and Logistics market?
3. What is the year over year growth of the global Cell and Gene Therapy Supply Chain and Logistics market?
4. What is the total value of the global Cell and Gene Therapy Supply Chain and Logistics market?
5. Who are the Major Players in the global Cell and Gene Therapy Supply Chain and Logistics market?
6. What are the growth factors driving the market demand?
Cell and Gene Therapy Supply Chain and Logistics refers to a comprehensive, professional management and transportation system designed to ensure the safety, efficiency, and traceability of CGT drugs throughout the entire process from production to patients. Its core challenges lie in the highly personalized nature, extremely short shelf life, and stringent cryogenic requirements of CGT products. This system encompasses cold chain collection and transportation of biological samples, global sourcing of raw materials required for GMP production, cryogenic distribution of finished drugs, and a real-time temperature monitoring and traceability system throughout the entire process. Each step must strictly adhere to GMP standards to ensure cell viability and sterility; any temperature deviation or delay can lead to product failure. As the lifeline connecting laboratories, factories, and clinical settings, a high-quality supply chain and logistics are crucial for the commercial success of CGT drugs.
The global Cell and Gene Therapy Supply Chain and Logistics market is experiencing rapid growth driven by the accelerated commercialization of CGT drugs and the globalization of clinical trials. North America and Europe, as mature markets, leverage their leading cold chain technologies, comprehensive air networks, and stringent regulations to hold leading positions in cryogenic cold chain logistics, supply chain traceability systems, and global temperature-controlled container services. The Asia-Pacific region is the fastest-growing and most demand-driven sector. China and Southeast Asian countries, driven by a surge in cell therapy clinical research, the expansion of local production facilities, and cross-border medical needs, are rapidly developing cryogenic transportation networks, integrating with hospital supply chains, and establishing real-time monitoring platforms, leading to the rapid rise of local logistics service providers. The industry as a whole is accelerating its evolution towards end-to-end visualization, unmanned intelligent monitoring, and global supply chain integration.
This report studies the global Cell and Gene Therapy Supply Chain and Logistics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy Supply Chain and Logistics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy Supply Chain and Logistics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell and Gene Therapy Supply Chain and Logistics total market, 2021-2032, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Cell and Gene Therapy Supply Chain and Logistics total market, key domestic companies, and share, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics revenue by player, revenue and market share 2021-2026, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics total market by Type, CAGR, 2021-2032, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Cell and Gene Therapy Supply Chain and Logistics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Be The Match BioTherapies, Biocair, Marken, World Courier, MAK-SYSTEM, Cryoport, Brooks Life Sciences, Hypertrust Patient Data Care, Haemonetics, MasterControl, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Cell and Gene Therapy Supply Chain and Logistics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Cell and Gene Therapy Supply Chain and Logistics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Ordering and Scheduling Services
- Sample Collection Services
- Logistics Services
- Post Treatment Follow-Up Services
- Deep Cryogenic Cold Chain Logistics (-150? to -80?)
- Ultra-Low Cryogenic Cold Chain Logistics (-20? to -80?)
- Refrigerated Logistics (2? to 8?)
- Ambient Temperature/Controlled Room Temperature Logistics (15? to 25?)
- Domestic/Regional Logistics
- Cross-Border Logistics
- Biobank
- Cell Therapy Lab
- Hospital
- Research Institute
- Be The Match BioTherapies
- Biocair
- Marken
- World Courier
- MAK-SYSTEM
- Cryoport
- Brooks Life Sciences
- Hypertrust Patient Data Care
- Haemonetics
- MasterControl
- TraceLink
- TrakCel
- Stafa Cellular Therapy
- McKesson
- BioLife Solutions
- Patheon
- SF Express
1. How big is the global Cell and Gene Therapy Supply Chain and Logistics market?
2. What is the demand of the global Cell and Gene Therapy Supply Chain and Logistics market?
3. What is the year over year growth of the global Cell and Gene Therapy Supply Chain and Logistics market?
4. What is the total value of the global Cell and Gene Therapy Supply Chain and Logistics market?
5. Who are the Major Players in the global Cell and Gene Therapy Supply Chain and Logistics market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cell and Gene Therapy Supply Chain and Logistics Introduction
1.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Cell and Gene Therapy Supply Chain and Logistics Total Market by Region (by Headquarter Location)
1.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
1.3.3 China Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
1.3.4 Europe Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
1.3.5 Japan Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
1.3.6 South Korea Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
1.3.7 ASEAN Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
1.3.8 India Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell and Gene Therapy Supply Chain and Logistics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032)
2.2 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region
2.2.1 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2021-2026)
2.2.2 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Region (2027-2032)
2.3 United States Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032)
2.4 China Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032)
2.5 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032)
2.6 Japan Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032)
2.7 South Korea Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032)
2.8 ASEAN Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032)
2.9 India Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032)
3 WORLD CELL AND GENE THERAPY SUPPLY CHAIN AND LOGISTICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell and Gene Therapy Supply Chain and Logistics Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell and Gene Therapy Supply Chain and Logistics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy Supply Chain and Logistics in 2025
3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy Supply Chain and Logistics in 2025
3.3 Cell and Gene Therapy Supply Chain and Logistics Company Evaluation Quadrant
3.4 Cell and Gene Therapy Supply Chain and Logistics Market: Overall Company Footprint Analysis
3.4.1 Cell and Gene Therapy Supply Chain and Logistics Market: Region Footprint
3.4.2 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
3.4.3 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Comparison
4.2.1 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Cell and Gene Therapy Supply Chain and Logistics Companies and Market Share, 2021-2026
4.3.1 United States Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2021-2026)
4.4 China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue and Market Share, 2021-2026
4.4.1 China Based Cell and Gene Therapy Supply Chain and Logistics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2021-2026)
4.5 Rest of World Based Cell and Gene Therapy Supply Chain and Logistics Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Ordering and Scheduling Services
5.2.2 Sample Collection Services
5.2.3 Logistics Services
5.2.4 Post Treatment Follow-Up Services
5.3 Market Segment by Type
5.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2021-2026)
5.3.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2027-2032)
5.3.3 World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TEMPERATURE
6.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size Overview by Temperature: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Temperature
6.2.1 Deep Cryogenic Cold Chain Logistics (-150? to -80?)
6.2.2 Ultra-Low Cryogenic Cold Chain Logistics (-20? to -80?)
6.2.3 Refrigerated Logistics (2? to 8?)
6.2.4 Ambient Temperature/Controlled Room Temperature Logistics (15? to 25?)
6.3 Market Segment by Temperature
6.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Temperature (2021-2026)
6.3.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Temperature (2027-2032)
6.3.3 World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Temperature (2027-2032)
7 MARKET ANALYSIS BY SCOPE
7.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size Overview by Scope: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Scope
7.2.1 Domestic/Regional Logistics
7.2.2 Cross-Border Logistics
7.3 Market Segment by Scope
7.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Scope (2021-2026)
7.3.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Scope (2027-2032)
7.3.3 World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Scope (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Biobank
8.2.2 Cell Therapy Lab
8.2.3 Hospital
8.2.4 Research Institute
8.3 Market Segment by Application
8.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2026)
8.3.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2027-2032)
8.3.3 World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Be The Match BioTherapies
9.1.1 Be The Match BioTherapies Details
9.1.2 Be The Match BioTherapies Major Business
9.1.3 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.1.4 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Be The Match BioTherapies Recent Developments/Updates
9.1.6 Be The Match BioTherapies Competitive Strengths & Weaknesses
9.2 Biocair
9.2.1 Biocair Details
9.2.2 Biocair Major Business
9.2.3 Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.2.4 Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Biocair Recent Developments/Updates
9.2.6 Biocair Competitive Strengths & Weaknesses
9.3 Marken
9.3.1 Marken Details
9.3.2 Marken Major Business
9.3.3 Marken Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.3.4 Marken Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Marken Recent Developments/Updates
9.3.6 Marken Competitive Strengths & Weaknesses
9.4 World Courier
9.4.1 World Courier Details
9.4.2 World Courier Major Business
9.4.3 World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.4.4 World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 World Courier Recent Developments/Updates
9.4.6 World Courier Competitive Strengths & Weaknesses
9.5 MAK-SYSTEM
9.5.1 MAK-SYSTEM Details
9.5.2 MAK-SYSTEM Major Business
9.5.3 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.5.4 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 MAK-SYSTEM Recent Developments/Updates
9.5.6 MAK-SYSTEM Competitive Strengths & Weaknesses
9.6 Cryoport
9.6.1 Cryoport Details
9.6.2 Cryoport Major Business
9.6.3 Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.6.4 Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Cryoport Recent Developments/Updates
9.6.6 Cryoport Competitive Strengths & Weaknesses
9.7 Brooks Life Sciences
9.7.1 Brooks Life Sciences Details
9.7.2 Brooks Life Sciences Major Business
9.7.3 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.7.4 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Brooks Life Sciences Recent Developments/Updates
9.7.6 Brooks Life Sciences Competitive Strengths & Weaknesses
9.8 Hypertrust Patient Data Care
9.8.1 Hypertrust Patient Data Care Details
9.8.2 Hypertrust Patient Data Care Major Business
9.8.3 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.8.4 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Hypertrust Patient Data Care Recent Developments/Updates
9.8.6 Hypertrust Patient Data Care Competitive Strengths & Weaknesses
9.9 Haemonetics
9.9.1 Haemonetics Details
9.9.2 Haemonetics Major Business
9.9.3 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.9.4 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Haemonetics Recent Developments/Updates
9.9.6 Haemonetics Competitive Strengths & Weaknesses
9.10 MasterControl
9.10.1 MasterControl Details
9.10.2 MasterControl Major Business
9.10.3 MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.10.4 MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 MasterControl Recent Developments/Updates
9.10.6 MasterControl Competitive Strengths & Weaknesses
9.11 TraceLink
9.11.1 TraceLink Details
9.11.2 TraceLink Major Business
9.11.3 TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.11.4 TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 TraceLink Recent Developments/Updates
9.11.6 TraceLink Competitive Strengths & Weaknesses
9.12 TrakCel
9.12.1 TrakCel Details
9.12.2 TrakCel Major Business
9.12.3 TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.12.4 TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 TrakCel Recent Developments/Updates
9.12.6 TrakCel Competitive Strengths & Weaknesses
9.13 Stafa Cellular Therapy
9.13.1 Stafa Cellular Therapy Details
9.13.2 Stafa Cellular Therapy Major Business
9.13.3 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.13.4 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Stafa Cellular Therapy Recent Developments/Updates
9.13.6 Stafa Cellular Therapy Competitive Strengths & Weaknesses
9.14 McKesson
9.14.1 McKesson Details
9.14.2 McKesson Major Business
9.14.3 McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.14.4 McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 McKesson Recent Developments/Updates
9.14.6 McKesson Competitive Strengths & Weaknesses
9.15 BioLife Solutions
9.15.1 BioLife Solutions Details
9.15.2 BioLife Solutions Major Business
9.15.3 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.15.4 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 BioLife Solutions Recent Developments/Updates
9.15.6 BioLife Solutions Competitive Strengths & Weaknesses
9.16 Patheon
9.16.1 Patheon Details
9.16.2 Patheon Major Business
9.16.3 Patheon Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.16.4 Patheon Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Patheon Recent Developments/Updates
9.16.6 Patheon Competitive Strengths & Weaknesses
9.17 SF Express
9.17.1 SF Express Details
9.17.2 SF Express Major Business
9.17.3 SF Express Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.17.4 SF Express Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 SF Express Recent Developments/Updates
9.17.6 SF Express Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Cell and Gene Therapy Supply Chain and Logistics Industry Chain
10.2 Cell and Gene Therapy Supply Chain and Logistics Upstream Analysis
10.3 Cell and Gene Therapy Supply Chain and Logistics Midstream Analysis
10.4 Cell and Gene Therapy Supply Chain and Logistics Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Cell and Gene Therapy Supply Chain and Logistics Introduction
1.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Cell and Gene Therapy Supply Chain and Logistics Total Market by Region (by Headquarter Location)
1.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
1.3.3 China Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
1.3.4 Europe Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
1.3.5 Japan Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
1.3.6 South Korea Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
1.3.7 ASEAN Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
1.3.8 India Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell and Gene Therapy Supply Chain and Logistics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032)
2.2 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region
2.2.1 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2021-2026)
2.2.2 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Region (2027-2032)
2.3 United States Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032)
2.4 China Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032)
2.5 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032)
2.6 Japan Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032)
2.7 South Korea Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032)
2.8 ASEAN Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032)
2.9 India Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032)
3 WORLD CELL AND GENE THERAPY SUPPLY CHAIN AND LOGISTICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell and Gene Therapy Supply Chain and Logistics Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell and Gene Therapy Supply Chain and Logistics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy Supply Chain and Logistics in 2025
3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy Supply Chain and Logistics in 2025
3.3 Cell and Gene Therapy Supply Chain and Logistics Company Evaluation Quadrant
3.4 Cell and Gene Therapy Supply Chain and Logistics Market: Overall Company Footprint Analysis
3.4.1 Cell and Gene Therapy Supply Chain and Logistics Market: Region Footprint
3.4.2 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
3.4.3 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Comparison
4.2.1 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Cell and Gene Therapy Supply Chain and Logistics Companies and Market Share, 2021-2026
4.3.1 United States Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2021-2026)
4.4 China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue and Market Share, 2021-2026
4.4.1 China Based Cell and Gene Therapy Supply Chain and Logistics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2021-2026)
4.5 Rest of World Based Cell and Gene Therapy Supply Chain and Logistics Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Ordering and Scheduling Services
5.2.2 Sample Collection Services
5.2.3 Logistics Services
5.2.4 Post Treatment Follow-Up Services
5.3 Market Segment by Type
5.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2021-2026)
5.3.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2027-2032)
5.3.3 World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TEMPERATURE
6.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size Overview by Temperature: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Temperature
6.2.1 Deep Cryogenic Cold Chain Logistics (-150? to -80?)
6.2.2 Ultra-Low Cryogenic Cold Chain Logistics (-20? to -80?)
6.2.3 Refrigerated Logistics (2? to 8?)
6.2.4 Ambient Temperature/Controlled Room Temperature Logistics (15? to 25?)
6.3 Market Segment by Temperature
6.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Temperature (2021-2026)
6.3.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Temperature (2027-2032)
6.3.3 World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Temperature (2027-2032)
7 MARKET ANALYSIS BY SCOPE
7.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size Overview by Scope: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Scope
7.2.1 Domestic/Regional Logistics
7.2.2 Cross-Border Logistics
7.3 Market Segment by Scope
7.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Scope (2021-2026)
7.3.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Scope (2027-2032)
7.3.3 World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Scope (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Biobank
8.2.2 Cell Therapy Lab
8.2.3 Hospital
8.2.4 Research Institute
8.3 Market Segment by Application
8.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2026)
8.3.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2027-2032)
8.3.3 World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Be The Match BioTherapies
9.1.1 Be The Match BioTherapies Details
9.1.2 Be The Match BioTherapies Major Business
9.1.3 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.1.4 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Be The Match BioTherapies Recent Developments/Updates
9.1.6 Be The Match BioTherapies Competitive Strengths & Weaknesses
9.2 Biocair
9.2.1 Biocair Details
9.2.2 Biocair Major Business
9.2.3 Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.2.4 Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Biocair Recent Developments/Updates
9.2.6 Biocair Competitive Strengths & Weaknesses
9.3 Marken
9.3.1 Marken Details
9.3.2 Marken Major Business
9.3.3 Marken Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.3.4 Marken Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Marken Recent Developments/Updates
9.3.6 Marken Competitive Strengths & Weaknesses
9.4 World Courier
9.4.1 World Courier Details
9.4.2 World Courier Major Business
9.4.3 World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.4.4 World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 World Courier Recent Developments/Updates
9.4.6 World Courier Competitive Strengths & Weaknesses
9.5 MAK-SYSTEM
9.5.1 MAK-SYSTEM Details
9.5.2 MAK-SYSTEM Major Business
9.5.3 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.5.4 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 MAK-SYSTEM Recent Developments/Updates
9.5.6 MAK-SYSTEM Competitive Strengths & Weaknesses
9.6 Cryoport
9.6.1 Cryoport Details
9.6.2 Cryoport Major Business
9.6.3 Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.6.4 Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Cryoport Recent Developments/Updates
9.6.6 Cryoport Competitive Strengths & Weaknesses
9.7 Brooks Life Sciences
9.7.1 Brooks Life Sciences Details
9.7.2 Brooks Life Sciences Major Business
9.7.3 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.7.4 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Brooks Life Sciences Recent Developments/Updates
9.7.6 Brooks Life Sciences Competitive Strengths & Weaknesses
9.8 Hypertrust Patient Data Care
9.8.1 Hypertrust Patient Data Care Details
9.8.2 Hypertrust Patient Data Care Major Business
9.8.3 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.8.4 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Hypertrust Patient Data Care Recent Developments/Updates
9.8.6 Hypertrust Patient Data Care Competitive Strengths & Weaknesses
9.9 Haemonetics
9.9.1 Haemonetics Details
9.9.2 Haemonetics Major Business
9.9.3 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.9.4 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Haemonetics Recent Developments/Updates
9.9.6 Haemonetics Competitive Strengths & Weaknesses
9.10 MasterControl
9.10.1 MasterControl Details
9.10.2 MasterControl Major Business
9.10.3 MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.10.4 MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 MasterControl Recent Developments/Updates
9.10.6 MasterControl Competitive Strengths & Weaknesses
9.11 TraceLink
9.11.1 TraceLink Details
9.11.2 TraceLink Major Business
9.11.3 TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.11.4 TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 TraceLink Recent Developments/Updates
9.11.6 TraceLink Competitive Strengths & Weaknesses
9.12 TrakCel
9.12.1 TrakCel Details
9.12.2 TrakCel Major Business
9.12.3 TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.12.4 TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 TrakCel Recent Developments/Updates
9.12.6 TrakCel Competitive Strengths & Weaknesses
9.13 Stafa Cellular Therapy
9.13.1 Stafa Cellular Therapy Details
9.13.2 Stafa Cellular Therapy Major Business
9.13.3 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.13.4 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Stafa Cellular Therapy Recent Developments/Updates
9.13.6 Stafa Cellular Therapy Competitive Strengths & Weaknesses
9.14 McKesson
9.14.1 McKesson Details
9.14.2 McKesson Major Business
9.14.3 McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.14.4 McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 McKesson Recent Developments/Updates
9.14.6 McKesson Competitive Strengths & Weaknesses
9.15 BioLife Solutions
9.15.1 BioLife Solutions Details
9.15.2 BioLife Solutions Major Business
9.15.3 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.15.4 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 BioLife Solutions Recent Developments/Updates
9.15.6 BioLife Solutions Competitive Strengths & Weaknesses
9.16 Patheon
9.16.1 Patheon Details
9.16.2 Patheon Major Business
9.16.3 Patheon Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.16.4 Patheon Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Patheon Recent Developments/Updates
9.16.6 Patheon Competitive Strengths & Weaknesses
9.17 SF Express
9.17.1 SF Express Details
9.17.2 SF Express Major Business
9.17.3 SF Express Cell and Gene Therapy Supply Chain and Logistics Product and Services
9.17.4 SF Express Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 SF Express Recent Developments/Updates
9.17.6 SF Express Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Cell and Gene Therapy Supply Chain and Logistics Industry Chain
10.2 Cell and Gene Therapy Supply Chain and Logistics Upstream Analysis
10.3 Cell and Gene Therapy Supply Chain and Logistics Midstream Analysis
10.4 Cell and Gene Therapy Supply Chain and Logistics Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Cell and Gene Therapy Supply Chain and Logistics Players in 2025
Table 12. World Cell and Gene Therapy Supply Chain and Logistics Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Cell and Gene Therapy Supply Chain and Logistics Company Evaluation Quadrant
Table 14. Head Office of Key Cell and Gene Therapy Supply Chain and Logistics Players
Table 15. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
Table 16. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
Table 17. Cell and Gene Therapy Supply Chain and Logistics Mergers & Acquisitions Activity
Table 18. United States VS China Cell and Gene Therapy Supply Chain and Logistics Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Cell and Gene Therapy Supply Chain and Logistics Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share (2021-2026)
Table 23. China Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share (2021-2026)
Table 26. Rest of World Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share (2021-2026)
Table 29. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Cell and Gene Therapy Supply Chain and Logistics Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2027-2032) & (USD Million)
Table 32. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Temperature, (USD Million), 2021 & 2025 & 2032
Table 33. World Cell and Gene Therapy Supply Chain and Logistics Market Size Value by Temperature (2021-2026) & (USD Million)
Table 34. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Temperature (2027-2032) & (USD Million)
Table 35. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Scope, (USD Million), 2021 & 2025 & 2032
Table 36. World Cell and Gene Therapy Supply Chain and Logistics Market Size Value by Scope (2021-2026) & (USD Million)
Table 37. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Scope (2027-2032) & (USD Million)
Table 38. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2026) & (USD Million)
Table 40. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2027-2032) & (USD Million)
Table 41. Be The Match BioTherapies Basic Information, Manufacturing Base and Competitors
Table 42. Be The Match BioTherapies Major Business
Table 43. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 44. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Be The Match BioTherapies Recent Developments/Updates
Table 46. Be The Match BioTherapies Competitive Strengths & Weaknesses
Table 47. Biocair Basic Information, Manufacturing Base and Competitors
Table 48. Biocair Major Business
Table 49. Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 50. Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Biocair Recent Developments/Updates
Table 52. Biocair Competitive Strengths & Weaknesses
Table 53. Marken Basic Information, Manufacturing Base and Competitors
Table 54. Marken Major Business
Table 55. Marken Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 56. Marken Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Marken Recent Developments/Updates
Table 58. Marken Competitive Strengths & Weaknesses
Table 59. World Courier Basic Information, Manufacturing Base and Competitors
Table 60. World Courier Major Business
Table 61. World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 62. World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. World Courier Recent Developments/Updates
Table 64. World Courier Competitive Strengths & Weaknesses
Table 65. MAK-SYSTEM Basic Information, Manufacturing Base and Competitors
Table 66. MAK-SYSTEM Major Business
Table 67. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 68. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. MAK-SYSTEM Recent Developments/Updates
Table 70. MAK-SYSTEM Competitive Strengths & Weaknesses
Table 71. Cryoport Basic Information, Manufacturing Base and Competitors
Table 72. Cryoport Major Business
Table 73. Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 74. Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Cryoport Recent Developments/Updates
Table 76. Cryoport Competitive Strengths & Weaknesses
Table 77. Brooks Life Sciences Basic Information, Manufacturing Base and Competitors
Table 78. Brooks Life Sciences Major Business
Table 79. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 80. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Brooks Life Sciences Recent Developments/Updates
Table 82. Brooks Life Sciences Competitive Strengths & Weaknesses
Table 83. Hypertrust Patient Data Care Basic Information, Manufacturing Base and Competitors
Table 84. Hypertrust Patient Data Care Major Business
Table 85. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 86. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Hypertrust Patient Data Care Recent Developments/Updates
Table 88. Hypertrust Patient Data Care Competitive Strengths & Weaknesses
Table 89. Haemonetics Basic Information, Manufacturing Base and Competitors
Table 90. Haemonetics Major Business
Table 91. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 92. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Haemonetics Recent Developments/Updates
Table 94. Haemonetics Competitive Strengths & Weaknesses
Table 95. MasterControl Basic Information, Manufacturing Base and Competitors
Table 96. MasterControl Major Business
Table 97. MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 98. MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. MasterControl Recent Developments/Updates
Table 100. MasterControl Competitive Strengths & Weaknesses
Table 101. TraceLink Basic Information, Manufacturing Base and Competitors
Table 102. TraceLink Major Business
Table 103. TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 104. TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. TraceLink Recent Developments/Updates
Table 106. TraceLink Competitive Strengths & Weaknesses
Table 107. TrakCel Basic Information, Manufacturing Base and Competitors
Table 108. TrakCel Major Business
Table 109. TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 110. TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. TrakCel Recent Developments/Updates
Table 112. TrakCel Competitive Strengths & Weaknesses
Table 113. Stafa Cellular Therapy Basic Information, Manufacturing Base and Competitors
Table 114. Stafa Cellular Therapy Major Business
Table 115. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 116. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Stafa Cellular Therapy Recent Developments/Updates
Table 118. Stafa Cellular Therapy Competitive Strengths & Weaknesses
Table 119. McKesson Basic Information, Manufacturing Base and Competitors
Table 120. McKesson Major Business
Table 121. McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 122. McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. McKesson Recent Developments/Updates
Table 124. McKesson Competitive Strengths & Weaknesses
Table 125. BioLife Solutions Basic Information, Manufacturing Base and Competitors
Table 126. BioLife Solutions Major Business
Table 127. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 128. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. BioLife Solutions Recent Developments/Updates
Table 130. BioLife Solutions Competitive Strengths & Weaknesses
Table 131. Patheon Basic Information, Manufacturing Base and Competitors
Table 132. Patheon Major Business
Table 133. Patheon Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 134. Patheon Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Patheon Recent Developments/Updates
Table 136. Patheon Competitive Strengths & Weaknesses
Table 137. SF Express Basic Information, Manufacturing Base and Competitors
Table 138. SF Express Major Business
Table 139. SF Express Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 140. SF Express Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. SF Express Recent Developments/Updates
Table 142. SF Express Competitive Strengths & Weaknesses
Table 143. Global Key Players of Cell and Gene Therapy Supply Chain and Logistics Upstream (Raw Materials)
Table 144. Global Cell and Gene Therapy Supply Chain and Logistics Typical Customers
Table 1. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Cell and Gene Therapy Supply Chain and Logistics Players in 2025
Table 12. World Cell and Gene Therapy Supply Chain and Logistics Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Cell and Gene Therapy Supply Chain and Logistics Company Evaluation Quadrant
Table 14. Head Office of Key Cell and Gene Therapy Supply Chain and Logistics Players
Table 15. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
Table 16. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
Table 17. Cell and Gene Therapy Supply Chain and Logistics Mergers & Acquisitions Activity
Table 18. United States VS China Cell and Gene Therapy Supply Chain and Logistics Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Cell and Gene Therapy Supply Chain and Logistics Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share (2021-2026)
Table 23. China Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share (2021-2026)
Table 26. Rest of World Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share (2021-2026)
Table 29. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Cell and Gene Therapy Supply Chain and Logistics Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2027-2032) & (USD Million)
Table 32. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Temperature, (USD Million), 2021 & 2025 & 2032
Table 33. World Cell and Gene Therapy Supply Chain and Logistics Market Size Value by Temperature (2021-2026) & (USD Million)
Table 34. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Temperature (2027-2032) & (USD Million)
Table 35. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Scope, (USD Million), 2021 & 2025 & 2032
Table 36. World Cell and Gene Therapy Supply Chain and Logistics Market Size Value by Scope (2021-2026) & (USD Million)
Table 37. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Scope (2027-2032) & (USD Million)
Table 38. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2026) & (USD Million)
Table 40. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2027-2032) & (USD Million)
Table 41. Be The Match BioTherapies Basic Information, Manufacturing Base and Competitors
Table 42. Be The Match BioTherapies Major Business
Table 43. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 44. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Be The Match BioTherapies Recent Developments/Updates
Table 46. Be The Match BioTherapies Competitive Strengths & Weaknesses
Table 47. Biocair Basic Information, Manufacturing Base and Competitors
Table 48. Biocair Major Business
Table 49. Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 50. Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Biocair Recent Developments/Updates
Table 52. Biocair Competitive Strengths & Weaknesses
Table 53. Marken Basic Information, Manufacturing Base and Competitors
Table 54. Marken Major Business
Table 55. Marken Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 56. Marken Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Marken Recent Developments/Updates
Table 58. Marken Competitive Strengths & Weaknesses
Table 59. World Courier Basic Information, Manufacturing Base and Competitors
Table 60. World Courier Major Business
Table 61. World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 62. World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. World Courier Recent Developments/Updates
Table 64. World Courier Competitive Strengths & Weaknesses
Table 65. MAK-SYSTEM Basic Information, Manufacturing Base and Competitors
Table 66. MAK-SYSTEM Major Business
Table 67. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 68. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. MAK-SYSTEM Recent Developments/Updates
Table 70. MAK-SYSTEM Competitive Strengths & Weaknesses
Table 71. Cryoport Basic Information, Manufacturing Base and Competitors
Table 72. Cryoport Major Business
Table 73. Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 74. Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Cryoport Recent Developments/Updates
Table 76. Cryoport Competitive Strengths & Weaknesses
Table 77. Brooks Life Sciences Basic Information, Manufacturing Base and Competitors
Table 78. Brooks Life Sciences Major Business
Table 79. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 80. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Brooks Life Sciences Recent Developments/Updates
Table 82. Brooks Life Sciences Competitive Strengths & Weaknesses
Table 83. Hypertrust Patient Data Care Basic Information, Manufacturing Base and Competitors
Table 84. Hypertrust Patient Data Care Major Business
Table 85. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 86. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Hypertrust Patient Data Care Recent Developments/Updates
Table 88. Hypertrust Patient Data Care Competitive Strengths & Weaknesses
Table 89. Haemonetics Basic Information, Manufacturing Base and Competitors
Table 90. Haemonetics Major Business
Table 91. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 92. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Haemonetics Recent Developments/Updates
Table 94. Haemonetics Competitive Strengths & Weaknesses
Table 95. MasterControl Basic Information, Manufacturing Base and Competitors
Table 96. MasterControl Major Business
Table 97. MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 98. MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. MasterControl Recent Developments/Updates
Table 100. MasterControl Competitive Strengths & Weaknesses
Table 101. TraceLink Basic Information, Manufacturing Base and Competitors
Table 102. TraceLink Major Business
Table 103. TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 104. TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. TraceLink Recent Developments/Updates
Table 106. TraceLink Competitive Strengths & Weaknesses
Table 107. TrakCel Basic Information, Manufacturing Base and Competitors
Table 108. TrakCel Major Business
Table 109. TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 110. TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. TrakCel Recent Developments/Updates
Table 112. TrakCel Competitive Strengths & Weaknesses
Table 113. Stafa Cellular Therapy Basic Information, Manufacturing Base and Competitors
Table 114. Stafa Cellular Therapy Major Business
Table 115. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 116. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Stafa Cellular Therapy Recent Developments/Updates
Table 118. Stafa Cellular Therapy Competitive Strengths & Weaknesses
Table 119. McKesson Basic Information, Manufacturing Base and Competitors
Table 120. McKesson Major Business
Table 121. McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 122. McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. McKesson Recent Developments/Updates
Table 124. McKesson Competitive Strengths & Weaknesses
Table 125. BioLife Solutions Basic Information, Manufacturing Base and Competitors
Table 126. BioLife Solutions Major Business
Table 127. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 128. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. BioLife Solutions Recent Developments/Updates
Table 130. BioLife Solutions Competitive Strengths & Weaknesses
Table 131. Patheon Basic Information, Manufacturing Base and Competitors
Table 132. Patheon Major Business
Table 133. Patheon Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 134. Patheon Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Patheon Recent Developments/Updates
Table 136. Patheon Competitive Strengths & Weaknesses
Table 137. SF Express Basic Information, Manufacturing Base and Competitors
Table 138. SF Express Major Business
Table 139. SF Express Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 140. SF Express Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. SF Express Recent Developments/Updates
Table 142. SF Express Competitive Strengths & Weaknesses
Table 143. Global Key Players of Cell and Gene Therapy Supply Chain and Logistics Upstream (Raw Materials)
Table 144. Global Cell and Gene Therapy Supply Chain and Logistics Typical Customers
LIST OF FIGURES
Figure 1. Cell and Gene Therapy Supply Chain and Logistics Picture
Figure 2. World Cell and Gene Therapy Supply Chain and Logistics Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Cell and Gene Therapy Supply Chain and Logistics Total Revenue (2021-2032) & (USD Million)
Figure 4. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032) & (USD Million)
Figure 13. Cell and Gene Therapy Supply Chain and Logistics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 16. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 18. China Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 23. India Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Cell and Gene Therapy Supply Chain and Logistics by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy Supply Chain and Logistics Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy Supply Chain and Logistics Markets in 2025
Figure 27. United States VS China: Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Type in 2025
Figure 31. Ordering and Scheduling Services
Figure 32. Sample Collection Services
Figure 33. Logistics Services
Figure 34. Post Treatment Follow-Up Services
Figure 35. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Type (2021-2032)
Figure 36. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Temperature, (USD Million), 2021 & 2025 & 2032
Figure 37. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Temperature in 2025
Figure 38. Deep Cryogenic Cold Chain Logistics (-150? to -80?)
Figure 39. Ultra-Low Cryogenic Cold Chain Logistics (-20? to -80?)
Figure 40. Refrigerated Logistics (2? to 8?)
Figure 41. Ambient Temperature/Controlled Room Temperature Logistics (15? to 25?)
Figure 42. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Temperature (2021-2032)
Figure 43. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Scope, (USD Million), 2021 & 2025 & 2032
Figure 44. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Scope in 2025
Figure 45. Domestic/Regional Logistics
Figure 46. Cross-Border Logistics
Figure 47. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Scope (2021-2032)
Figure 48. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Application in 2025
Figure 50. Biobank
Figure 51. Cell Therapy Lab
Figure 52. Hospital
Figure 53. Research Institute
Figure 54. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Application (2021-2032)
Figure 55. Cell and Gene Therapy Supply Chain and Logistics Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. Cell and Gene Therapy Supply Chain and Logistics Picture
Figure 2. World Cell and Gene Therapy Supply Chain and Logistics Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Cell and Gene Therapy Supply Chain and Logistics Total Revenue (2021-2032) & (USD Million)
Figure 4. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2021-2032) & (USD Million)
Figure 13. Cell and Gene Therapy Supply Chain and Logistics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 16. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 18. China Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 23. India Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Cell and Gene Therapy Supply Chain and Logistics by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy Supply Chain and Logistics Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy Supply Chain and Logistics Markets in 2025
Figure 27. United States VS China: Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Type in 2025
Figure 31. Ordering and Scheduling Services
Figure 32. Sample Collection Services
Figure 33. Logistics Services
Figure 34. Post Treatment Follow-Up Services
Figure 35. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Type (2021-2032)
Figure 36. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Temperature, (USD Million), 2021 & 2025 & 2032
Figure 37. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Temperature in 2025
Figure 38. Deep Cryogenic Cold Chain Logistics (-150? to -80?)
Figure 39. Ultra-Low Cryogenic Cold Chain Logistics (-20? to -80?)
Figure 40. Refrigerated Logistics (2? to 8?)
Figure 41. Ambient Temperature/Controlled Room Temperature Logistics (15? to 25?)
Figure 42. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Temperature (2021-2032)
Figure 43. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Scope, (USD Million), 2021 & 2025 & 2032
Figure 44. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Scope in 2025
Figure 45. Domestic/Regional Logistics
Figure 46. Cross-Border Logistics
Figure 47. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Scope (2021-2032)
Figure 48. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Application in 2025
Figure 50. Biobank
Figure 51. Cell Therapy Lab
Figure 52. Hospital
Figure 53. Research Institute
Figure 54. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Application (2021-2032)
Figure 55. Cell and Gene Therapy Supply Chain and Logistics Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
